James Sidaway

ESTP Congress
james.sidaway@apconix.com
,

James is an innovative mechanistic toxicologist with over 25 years of experience in the pharmaceutical industry. As a molecular-investigative toxicologist at AstraZeneca, he helped resolve safety issues for drug discovery and development projects across the major therapy areas. At AstraZeneca and as an independent consultant, he pioneered advanced in vitro models for organ toxicity screening and applied novel technology and informatics platforms for safety assessment. In 2021, James joined ApconiX, a UK-based company specializing in nonclinical toxicology and ion channel electrophysiology, to enhance its target safety assessment function. He is now head of ApconiX’s Safety Science Group, leading over 20 toxicologists and data scientists to deliver target safety and drug toxicity solutions through expert insight and state-of-the-art informatics.